Axsome Therapeutics (AXSM) Beats Q4 Earnings Estimates by $0.16

Axsome Therapeutics (NASDAQ:AXSM) reported quarterly earnings results on February 23, 2026 that exceeded analyst expectations.

The Healthcare company reported earnings per share of $-0.56, beating the consensus estimate of $-0.72 by $0.16 per share. Revenue came in at $196.0M, beating the estimate of $193.2M.

Axsome Therapeutics's stock moved following the earnings release. The stock currently trades at $171.07 with a market capitalization of $7.5B.